AWP
ALNY icon

Ascent Wealth Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ascent Wealth Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,000
Closed -$219K – 139
2018
Q4 		$219K Hold
3,000
– – 0.09% 111
2018
Q3 		$263K Hold
3,000
– – 0.08% 116
2018
Q2 		$295K Hold
3,000
– – 0.1% 104
2018
Q1 		$357K Hold
3,000
– – 0.13% 98
2017
Q4 		$381K Hold
3,000
– – 0.14% 98
2017
Q3 		$352K Hold
3,000
– – 0.14% 96
2017
Q2 		$239K Sell
3,000
-970
-24% -$62K 0.1% 108
2017
Q1 		$203K Buy
+3,970
New +$183K 0.09% 117

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return